James Leukemia Research Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from James Leukemia Research Program. Real-time updates on events, politics, business and more.

Chronic Lymphocytic Leukemia Headlines from 2023

September 28, 2023

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023.

Dana Farber Cancer Institute United States Ianw Flinn Jenniferr Brown Jennifer Woyach University Of Cologne

Source: curetoday.com

Triplet Therapy May Not Provide Additional Benefit in Older Patients With CLL

June 27, 2023

Patients 65 years and older treated with Venclexta, Imbruvica and Gazyva for CLL had similar rates of progression-free survival compared with those treated with Imbruvica and Gazyva.

United States Jennifer Woyach James Leukemia Research Program Ohio State University Comprehensive Cancer Center American Society Of Clinical Oncology Annual Meeting Adding Venclexta

Source: curetoday.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

James Leukemia Research Program News Today

Chronic Lymphocytic Leukemia Headlines from 2023

Triplet Therapy May Not Provide Additional Benefit in Older Patients With CLL

Explore More Categories